HDP1.F
Arrowhead Pharmaceuticals, Inc.
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
73.26
▼ 1.16 (1.56%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
73.98
Prev close
74.42
Day high
73.98
Day low
73.26
Volume
57
Market cap
$10.35B
P/E (TTM)
—
52W range
17.68 – 80.72
Day trading desk
Gap from prior close
-0.59%
Prior close 74.42
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
0.98%
73.26 – 73.98
Position in range
0%
Near session low
ATR (14D)
1.89
2.58% of price
Prior day high
74.42
PDH
Prior day low
73.72
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 12
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-3.83%
-2.7%
1M
-2.03%
-5.4%
3M
+7.74%
+5.3%
6M
+35.12%
+23.2%
YTD
+26.53%
+14.5%
1Y
+305.54%
+285.4%
3Y
+195.40%
+120.4%
5Y
+35.52%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on HDP1.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
5.17M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 18, 26 | OLUKOTUN ADEOYE Y Director |
SELL | 2.00K | $173.92K | Direct |
| Aug 18, 26 | PERRY MICHAEL S Director |
SELL | 11.60K | $1.01M | Direct |
| Jun 15, 26 | COHEN MATTHEW GREGORY Director |
STOCK | 11.88K | $0 | Direct |
| May 12, 26 | LU HONGBO B Director |
SELL | 2.97K | $228.33K | Direct |
| Apr 23, 26 | HAMILTON JAMES C Officer |
SELL | 10.00K | $750.00K | Direct |
| Apr 22, 26 | APEL DANIEL JOSEPH Chief Financial Officer |
SELL | 13.10K | $934.28K | Direct |
| Mar 5, 26 | HAMILTON JAMES C Officer |
SELL | 10.00K | $641.90K | Direct |
| Jan 6, 26 | O'BRIEN PATRICK C Chief Operating Officer |
STOCK | 2.50K | $0 | Direct |
| Jan 6, 26 | HAMILTON JAMES C Officer |
STOCK | 75.00K | $0 | Direct |
| Jan 6, 26 | APEL DANIEL JOSEPH Chief Financial Officer |
STOCK | 75.00K | $0 | Direct |
| Jan 6, 26 | O'BRIEN PATRICK C Chief Operating Officer |
STOCK | 75.00K | $0 | Direct |
| Jan 5, 26 | O'BRIEN PATRICK C Chief Operating Officer |
SELL | 49.49K | $3.12M | Direct |
| Jan 5, 26 | HAMILTON JAMES C Officer |
SELL | 40.16K | $2.53M | Direct |
| Jan 2, 26 | ANZALONE CHRISTOPHER RICHARD Chief Executive Officer |
SELL | 13.19K | $871.70K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ANZALONE CHRISTOPHER RICHARD |
Chief Executive Officer | 3.79M | Sale |
APEL DANIEL JOSEPH |
Chief Financial Officer | 162.91K | Sale |
FERRARI MAURO |
Director | 69.05K | Sale |
GIVEN DOUGLAS BRUCE |
Director | 124.17K | Sale |
HAMILTON JAMES C |
Officer | 226.96K | Sale |
LU HONGBO B |
Director | 52.01K | Sale |
MYSZKOWSKI KENNETH ALLEN |
Chief Financial Officer | 455.43K | Sale |
O'BRIEN PATRICK C |
Chief Operating Officer | 547.41K | Stock Gift |
PERRY MICHAEL S |
Director | 111.46K | Sale |
WADDILL WILLIAM D |
Director | 56.56K | Sale |
Fundamentals
Market cap$10.35B
Enterprise value$10.29B
Revenue (TTM)$669.49M
Gross profit$669.49M
EBITDA$-200.64M
Net income$-319.96M
EPS (TTM)$-1.95
Free cash flow$-48.63M
Total cash$1.60B
Total debt$1.38B
Book value / share$2.82
Shares outstanding141.25M
Float122.45M
Short % of float—
Dividend yield—
Beta (5Y)1.29
Valuation & profitability ratios
Trailing P/E—
Forward P/E-152.63
PEG ratio—
Price / sales—
Price / book25.96
EV / revenue15.38
EV / EBITDA-51.31
Gross margin100.00%
Operating margin-226.03%
Profit margin-47.79%
Return on equity-55.21%
Return on assets-8.10%
Debt / equity295.98
Current ratio5.90
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $829.45M | $3.55M | $240.74M | $243.23M | +23,258.2% |
| Operating revenue | $829.45M | $3.55M | $240.74M | $243.23M | +23,258.2% |
| Research & development | $607.16M | $505.87M | $353.19M | $297.31M | +20.0% |
| Selling, general & admin | $121.92M | $96.82M | $90.93M | $124.43M | +25.9% |
| Total operating expense | $731.10M | $604.63M | $445.74M | $421.74M | +20.9% |
| Operating income | $98.35M | -$601.08M | -$205.00M | -$178.51M | +116.4% |
| Net interest income | -$52.07M | -$9.63M | -$3.03M | $5.03M | -440.6% |
| Pre-tax income | $51.53M | -$612.46M | -$206.49M | -$172.71M | +108.4% |
| Tax provision | $21.42M | -$2.77M | $2.78M | $3.79M | +874.1% |
| Net income | -$1.63M | -$599.49M | -$205.28M | -$176.06M | +99.7% |
| Net income to common | -$1.63M | -$599.49M | -$205.28M | -$176.06M | +99.7% |
| Basic EPS | -0.01 | -5.00 | -1.91 | -1.63 | +99.8% |
| Diluted EPS | -0.01 | -5.00 | -1.92 | -1.67 | +99.8% |
| EBIT | $140.89M | -$580.11M | -$188.16M | -$172.71M | +124.3% |
| EBITDA | $164.82M | -$561.51M | -$175.67M | -$162.29M | +129.4% |
| Basic shares | 133.76M | 119.78M | 107.31M | 105.96M | +11.7% |
| Diluted shares | 133.76M | 119.78M | 107.31M | 105.96M | +11.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $88.71M | $76.21M | $110.89M | $108.00M | +16.4% |
| Cash & short-term investments | $919.37M | $680.96M | $403.63M | $376.40M | +35.0% |
| Accounts receivable | $6.82M | $0 | $0 | $1.41M | — |
| Total current assets | $950.64M | $695.47M | $416.47M | $405.30M | +36.7% |
| Property, plant & equipment | $426.41M | $431.29M | $335.56M | $168.59M | -1.1% |
| Goodwill & intangibles | $6.86M | $8.56M | $10.26M | $11.96M | -19.9% |
| Total assets | $1.39B | $1.14B | $765.55M | $691.94M | +21.5% |
| Total current liabilities | $195.49M | $103.17M | $105.46M | $138.85M | +89.5% |
| Current debt | $40.00M | — | — | — | — |
| Long-term debt | $214.88M | $393.18M | — | — | -45.3% |
| Total debt | $366.28M | $510.55M | $115.17M | $81.58M | -28.3% |
| Total liabilities | $881.88M | $948.74M | $478.39M | $273.60M | -7.0% |
| Retained earnings | -$1.63B | -$1.63B | -$1.03B | -$820.75M | -0.1% |
| Shareholder equity | $466.05M | $185.44M | $271.34M | $398.52M | +151.3% |
| Working capital | $755.15M | $592.30M | $311.02M | $266.45M | +27.5% |
| Net tangible assets | $459.19M | $176.88M | $261.08M | $386.56M | +159.6% |
| Shares issued | 138.36M | 124.38M | 107.31M | 105.96M | +11.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $30.11M | -$609.69M | -$209.28M | -$176.49M | +104.9% |
| Depreciation & amortisation | $23.93M | $18.59M | $12.49M | $10.42M | +28.7% |
| Stock-based compensation | $63.37M | $73.97M | $78.13M | $120.89M | -14.3% |
| Change in working capital | -$18.23M | $25.09M | -$51.55M | -$98.29M | -172.7% |
| Operating cash flow | $179.55M | -$462.85M | -$153.89M | -$136.13M | +138.8% |
| Capital expenditure | -$22.67M | -$141.47M | -$176.74M | -$52.78M | +84.0% |
| Investing cash flow | -$129.29M | -$420.07M | -$96.16M | -$5.42M | +69.2% |
| Financing cash flow | $74.01M | $870.52M | $253.05M | $65.19M | -91.5% |
| Free cash flow | $156.89M | -$604.32M | -$330.63M | -$188.91M | +126.0% |
| End cash position | $226.55M | $102.69M | $110.89M | $108.00M | +120.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $75.25M | $73.74M | $264.03M | $256.47M | $27.77M | — | +2.1% |
| Operating revenue | $75.25M | $73.74M | $264.03M | $256.47M | $27.77M | — | +2.1% |
| Research & development | $198.22M | $173.25M | $177.20M | $174.69M | $162.37M | — | +14.4% |
| Selling, general & admin | $46.63M | $41.24M | $45.52M | $37.18M | $30.44M | — | +13.1% |
| Total operating expense | $245.35M | $215.00M | $223.22M | $212.37M | $193.32M | — | +14.1% |
| Operating income | -$170.09M | -$141.26M | $40.81M | $44.11M | -$165.55M | — | -20.4% |
| Net interest income | -$7.63M | -$6.98M | -$12.81M | -$12.64M | -$13.36M | — | -9.3% |
| Pre-tax income | -$178.91M | -$137.56M | $28.27M | $36.12M | -$179.09M | — | -30.1% |
| Tax provision | $11.00K | $7.00K | $29.00K | $20.00M | -$437.00K | — | +57.1% |
| Net income | -$194.28M | -$132.73M | $30.81M | -$23.75M | -$175.24M | — | -46.4% |
| Net income to common | -$194.28M | -$132.73M | $30.81M | -$23.75M | -$175.24M | — | -46.4% |
| Basic EPS | -1.36 | -0.93 | 0.22 | — | -1.26 | 2.78 | -46.2% |
| Diluted EPS | -1.36 | -0.93 | 0.22 | — | -1.26 | 2.75 | -46.2% |
| EBIT | -$154.34M | -$113.72M | $50.78M | $57.81M | -$154.71M | — | -35.7% |
| EBITDA | -$147.68M | -$107.35M | $57.17M | $64.20M | -$148.48M | — | -37.6% |
| Basic shares | 143.38M | 142.42M | 137.04M | — | 139.04M | 133.36M | +0.7% |
| Diluted shares | 143.38M | 142.42M | 140.71M | — | 139.04M | 134.48M | +0.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $19.68M | $147.53M | $71.37M | $88.71M | $129.79M | -86.7% |
| Cash & short-term investments | $1.60B | $1.78B | $916.61M | $919.37M | $900.37M | -10.2% |
| Accounts receivable | $8.56M | $15.69M | $218.87M | $6.82M | $9.70M | -45.5% |
| Total current assets | $1.67B | $1.84B | $1.17B | $950.64M | $946.92M | -9.2% |
| Property, plant & equipment | $428.97M | $417.62M | $421.94M | $426.41M | $425.05M | +2.7% |
| Goodwill & intangibles | $5.59M | $6.01M | $6.44M | $6.86M | $7.29M | -7.1% |
| Total assets | $2.11B | $2.27B | $1.60B | $1.39B | $1.38B | -6.9% |
| Total current liabilities | $283.35M | $295.22M | $347.43M | $195.49M | $194.53M | -4.0% |
| Current debt | $40.00M | $40.00M | $40.00M | $40.00M | $40.00M | 0.0% |
| Long-term debt | $824.07M | $841.58M | $163.11M | $214.88M | $200.33M | -2.1% |
| Total debt | $983.69M | $989.46M | $312.77M | $366.28M | $353.03M | -0.6% |
| Total liabilities | $1.65B | $1.67B | $1.04B | $881.88M | $860.81M | -1.4% |
| Retained earnings | -$1.92B | -$1.73B | -$1.60B | -$1.63B | -$1.60B | -11.2% |
| Shareholder equity | $465.53M | $613.98M | $568.42M | $466.05M | $522.31M | -24.2% |
| Working capital | $1.39B | $1.54B | $826.96M | $755.15M | $752.39M | -10.1% |
| Net tangible assets | $459.94M | $607.97M | $561.99M | $459.19M | $515.03M | -24.3% |
| Shares issued | 141.13M | 143.23M | 140.05M | 138.36M | 138.14M | -1.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$178.92M | -$137.57M | $28.24M | $16.12M | -$178.65M | -30.1% |
| Depreciation & amortisation | $6.66M | $6.37M | $6.39M | $6.39M | $6.22M | +4.6% |
| Stock-based compensation | $14.87M | $16.67M | $19.37M | $19.09M | $13.04M | -10.8% |
| Change in working capital | -$45.51M | $188.15M | -$61.79M | -$38.36M | -$17.96M | -124.2% |
| Operating cash flow | -$177.47M | $84.44M | $13.48M | $20.49M | -$154.72M | -310.2% |
| Capital expenditure | -$3.85M | -$2.56M | -$2.15M | -$7.49M | -$2.36M | -50.3% |
| Investing cash flow | $43.68M | -$894.28M | -$23.74M | $72.62M | $141.39M | +104.9% |
| Financing cash flow | -$449.00K | $795.72M | -$14.75M | $3.67M | -$42.68M | -100.1% |
| Free cash flow | -$181.32M | $81.88M | $11.33M | $13.00M | -$157.08M | -321.5% |
| End cash position | $54.76M | $188.52M | $201.64M | $226.55M | $129.79M | -71.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $69.95M | -72.7% |
| Next quarter | — | — | $36.60M | -86.1% |
| Current year | — | — | $462.59M | -44.2% |
| Next year | — | — | $339.43M | -26.6% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders3.66%
Held by institutions85.57%
Institutions holding651
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
75.13
-2.49% from price
SMA 20
75.16
-2.53% from price
SMA 50
72.09
+1.63% from price
SMA 100
67.25
+8.93% from price
SMA 200
59.40
+23.32% from price
EMA 12
74.78
-2.03% from price
EMA 26
73.90
-0.86% from price
EMA 50
71.77
+2.08% from price
RSI (14)
48.5
Neutral
MACD (12,26,9)
0.89
Hist -0.44
ATR (14)
1.89
2.58% of price
Realised vol 30D
62.2%
Annualised
Bollinger upper
77.35
20, 2σ
Bollinger lower
72.97
20, 2σ
50 / 200 cross
Golden
72.09 vs 59.40
Trend bias
Above 200
+23.32%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.11
Less volatile than market
Correlation to SPY
0.02
Largely independent
Realised vol 30D
62.2%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-22.8%
Peak to trough
Max drawdown 5Y
-87.4%
Peak to trough
ATR 14
1.89
2.58% of price
Beta (reported)
1.29
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 6, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jul 30, 26 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Jul 27, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jul 23, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Jul 23, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jul 22, 26 | Chardan Capital | MAINTAINED | Buy | Buy |
| Jul 17, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jul 14, 26 | Stifel | INITIATED | — | Buy |
| Jul 1, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jun 30, 26 | Chardan Capital | MAINTAINED | Buy | Buy |
| Jun 17, 26 | Leerink Partners | MAINTAINED | Market Perform | Market Perform |
| May 13, 26 | Bernstein | MAINTAINED | Market Perform | Market Perform |
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:10
Split dateNov 17, 2011
Headlines
Peako to launch UAV magnetic surveys across five Saudi projects
Mining Technology · 1m ago
Canada's Carney to Announce New Investments to Strengthen Trade Routes After US Talks Collapse
MT Newswires · 3m ago
Leidos Wins $301 Million Cyber Defense Contract
MT Newswires · 5m ago
Davidson Kempner Capital Management LP : Form 8.3 - easyJet plc
GlobeNewswire · 6m ago
Billionaire Stanley Druckenmiller Bought Amazon and Alphabet in Q2. But His Single Biggest Holding Is Neither of Them -- and It's Not Nvidia Either.
Motley Fool · 6m ago
United Vein & Vascular Centers Expands Tampa Bay Network With New South Tampa Vein Clinic
PR Newswire · 7m ago
Brake problems in GM EVs draw greater federal scrutiny
TechCrunch · 7m ago
BetterHelp Has the Demand: Can Teladoc Build the Capacity?
Zacks · 8m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.